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INTRODUCTION 
 
There are two mosquito-borne diseases of concern in Massachusetts, Eastern equine encephalitis 
(EEE), which was identified as a human disease in 1938, and West Nile virus (WNV) infection, 
which has been present since 2000. EEE is a rare but serious neuroinvasive disease that causes 
meningitis or encephalitis, and often results in death or severe disability. WNV infection is more 
common, though typically less severe than EEE; presentation of WNV ranges from febrile illness 
to neuroinvasive disease. Although up to 51 different species of mosquitoes have been identified 
in Massachusetts, only a few of these contribute to either WNV or EEE spread. For more 
information, visit the MDPH website to view Common Mosquitoes That Can Spread Disease in 
Massachusetts. 
 
Currently there are no available vaccines to prevent human infections from either mosquito-
borne virus. Personal protection measures that serve to reduce exposure to mosquitoes and 
thereby prevent human infection remain the mainstay of prevention. To estimate the risk of 
human disease during a mosquito season, the MDPH, in cooperation with the local Mosquito 
Control Projects, conducts surveillance for EEE and WNV using mosquito samples, and 
specimens from human and veterinary sources. Detailed information about surveillance for these 
diseases in Massachusetts is available on the MDPH website at Arbovirus Surveillance and 
Control Plan. 
 
EASTERN EQUINE ENCEPHALITIS VIRUS 
 
Humans 
There were no human cases of EEE infection was identified in Massachusetts in 2014. There was 
one human case of EEE infection in 2013. 
 
Mosquito Samples 
Of 5,039 mosquito samples collected in Massachusetts in 2014, 33 (0.7%) were positive for EEE 
virus in 2014. Positive mosquito samples included 24 (76%) Culiseta melanura, five (15%) 
Coquillettidia perturbans, two (6%) Culex species and one (3%) Urotania sappherina. Positive 
samples were identified from 13 towns in four counties. For a complete list of positive mosquito 
samples by city/town, please see the Mosquito Summary by County and Municipality report 
posted on the MDPH website. 
 
Animals  
Seven veterinary samples were submitted for arbovirus testing.  Two animal cases of EEE 
infection were identified in Massachusetts in 2014. 
City or Town Animal Species Onset Date Virus Result  
Freetown Deer 8/9/2014 EEE 
Westminster Horse 10/5/2014 EEE 
 
Birds 
Although birds are not routinely tested as part of EEE surveillance, species such as emus or 
exotic quail may experience sudden illness and mortality due to EEE. Farmed birds showing 
these signs must be reported promptly to the Massachusetts Department of Agricultural 
Resources (MDAR). 
 
EEE Geographic Risk Levels 
EEE risk maps combine historical data and areas of mosquito habitat with current data on 
positive virus isolations (in humans, mosquitoes, etc.) and weather conditions. Risk levels are an 
estimate of the likelihood of an outbreak of human disease and are updated regularly with new 
surveillance data. Initial and final EEE risk levels from the 2014 season are provided in the 
following maps. This information will be used to help anticipate risk in 2015, and will be revised 
as 2015 surveillance data are collected. More detailed information about risk assessment and risk 
levels is available in the Arbovirus Surveillance and Response Plan on the MDPH web site. 
 
Initial and Final 2014 EEE Risk Categories 
 
 (As defined in Table 2 of the MDPH Arbovirus Surveillance and Response Plan which can be 
found at www.mass.gov/dph/mosquito under “Information for Local Boards of Health”) 
 
 
2014 EEE SEASON DISCUSSION 
 
There were no confirmed human EEE cases in 2014, compared to one confirmed human case 
identified in 2013 and seven confirmed human cases in 2012. The number of confirmed human 
cases nationwide was lower in 2014 (eight) and 2013 (five) when compared to 2012 (15).   
 
There was a similar decline in EEE virus positive mosquito samples from 267 in 2012 to 61 in 
2013, down to 33 in 2014. In 2014, MDPH identified 24 EEE positive samples of Culiseta 
melanura, the enzootic vector of EEE, compared to 46 EEE positive samples of Culiseta 
melanura in 2013. Mosquito surveillance activities are highly adaptive to identifications of EEE 
virus, with more mosquito trapping and testing in years when EEE activity is increased, this 
makes year-to-year comparisons somewhat difficult. In general, years with increased EEE 
human infections can be associated with a similar increase in the percentage of Cs. melanura 
samples that test positive for EEE virus (see figure below). 
  
Why was there less EEE activity in 2013 and 2014 than 2012? 
 
Historically, EEE outbreaks have rarely occurred over periods lasting more than three years, 
although evidence suggests that previously observed patterns may be changing and the situation 
must be monitored carefully. Intense EEE activity consistent with outbreaks occurred in 2004-
2006 and 2010-2012. Outbreaks are probably supported, in part, by previously unexposed 
populations of birds that are susceptible to EEE virus infection, and therefore capable of 
maintaining the cycle of virus transmission. Current research suggests that each of these cycles is 
associated with the introduction of a new strain of EEE virus. After three years of intense virus 
activity, the population of susceptible birds may not have been adequate to maintain the virus 
cycle. Important factors impacting EEE virus cycles include large Cs. melanura mosquito 
populations which are more likely to support significant EEE activity, and weather conditions, 
such as significant precipitation events and prolonged periods of high temperature. In 2012, 
significant precipitation and prolonged periods of high temperature provided favorable 
conditions for mosquito development. In  2013, mosquito season began with above-average 
precipitation, but precipitation declined midway through the season and cooler evening 
temperatures occurred during prime transmission season; causing a delay in development of new 
mosquitoes. In 2014, limited spring and summer precipitation produced similar declines in the 
numbers of new mosquitoes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Massachusetts, human EEE is 
associated with Culiseta melanura 
activity. The map to the right 
illustrates that the area of highest risk 
for transmission of EEE continues to 
be southeastern Massachusetts which 
is the historic area of risk. 
  
Over the last ten years, human EEE has occurred outside of the historic areas of risk and has 
shown significant variability in geographic patterns of occurrence during three successive time 
periods, indicated below. Cases are mapped by most likely county of exposure, rather than 
county of residence. 
 
                                   
    
 
 
 
 
 
 
 
 
What are the expectations for EEE in 2015? 
 
Mosquito abundance and vector-borne disease risk are affected by multiple environmental 
factors which vary over time and geographic location. The two most important contributors to 
mosquito development are precipitation and temperature. All species of mosquito depend on the 
presence of water for the first stages of life. Mosquito populations increase when precipitation is 
plentiful and decrease during dry periods. Warmer temperatures shorten both the time it takes for 
mosquitoes to develop from egg to adult and the time it takes for a mosquito to be able to 
transmit a pathogen after ingesting an infected blood meal. 
 
Warm and wet winters increase the likelihood of mosquito survival and lead to higher spring 
mosquito numbers. Although the winter of 2015 saw historic snowfall totals, both the fall of 
2014 and spring of 2015 were relatively dry. Reports from the field indicate below normal 
numbers of juvenile Culiseta melanura prior to the beginning of the season. 
 
Mosquito populations alone are not sufficient to produce significant EEE risk; infected bird 
populations are also necessary.  Unfortunately, less is known about the factors that lead to large 
numbers of infected birds, making this component of risk impossible to predict. At this time 
there is no efficient method to conduct surveillance for infection levels in wild birds.  
 
Both the variability of New England weather and the inability to detect EEE virus infection 
levels in wild bird populations require that Massachusetts maintain a robust surveillance system 
to detect EEE virus in mosquitoes as a tool to assess risk of human disease. 
 
 
 
  
WEST NILE VIRUS  
 
Humans 
There were six human cases of WNV infection identified in Massachusetts in 2014. The results 
are summarized in the table below. 
 
County Age Range Onset Date Virus Result  Clinical Presentation 
Essex 51-60 8/30/2014 WNV meningitis 
Middlesex 41-50 9/28/2014 WNV meningoencephalitis 
Middlesex 21-30 9/5/2014 WNV fever 
Middlesex 41-50 8/22/2014 WNV meningoencephalitis 
Middlesex 61-70 8/11/2014 WNV meningoencephalitis 
Middlesex 41-50 9/15/2014 WNV meningitis 
 
 
Presumptive Viremic Blood Donors 
WNV is transmissible through blood transfusion. Since June 2003, blood banks have screened 
donated blood for WNV using direct tests for viral genetic material. Positive units are not used 
and donors are deferred from future donation for 120 days.  The AABB (formerly the American 
Association of Blood Banks) notifies states of all presumptive viremic donors (PVDs) - 
individuals whose donated blood tests positive using a nucleic acid test (NAT).   
 
There was one presumptive viremic donor identified in Massachusetts in 2013. The number of 
presumptive viremic donors nationwide was approximately the same in 2014 (321) compared 
with 2013 (304). 
 
County Donation Date 
Middlesex 9/2/2014 
 
Mosquito Samples 
Of 5,039 mosquito samples collected in Massachusetts in 2014, 56 (1.1%) were positive for 
WNV. Positive mosquito samples included 52 (93%) Culex species.  Positive samples were 
identified in 29 towns in nine counties. For a complete list of positive mosquito samples by 
city/town, please see the 2014. Mosquito Summary by County and Municipality report posted on 
the MDPH website. 
 
Animals 
Seven veterinary samples were submitted for arbovirus testing. There were no horses that tested 
positive for WNV in 2014. 
 
WNV Geographic Risk Levels 
WNV risk maps are produced by integrating historical data and areas of mosquito habitat with 
current data on positive virus identifications (in humans, mosquitoes, etc.) and weather 
conditions. Risk levels serve as a relative measure of the likelihood of an outbreak of human 
disease and are updated weekly based on that week’s surveillance data. Initial and final WNV 
risk levels from the 2014 season are provided in the following maps. This information will be 
used to help predict risk in 2015, and will be revised as 2015 surveillance data are collected. 
  
More detailed information about risk assessment and risk levels is available in the Arbovirus 
Surveillance and Response Plan on the MDPH web site during the arbovirus season. 
 
Initial and Final 2014 WNV Risk Categories 
 (As described in Table1 of the 2014 MDPH Arbovirus Surveillance and Response Plan which 
can be found at www.mass.gov/dph/mosquito under “Information for Local Boards of Health”) 
 
                                                                            
2014 WNV SEASON DISCUSSION 
 
MDPH identified six confirmed human WNV infections in 2014 compared to eight confirmed 
cases in 2013 and 33 confirmed human cases identified in 2012.  This decrease in human cases 
was also seen across the country, where the number of confirmed human cases nationwide was 
much lower in both 2014(1,935) and 2013 (2,271) compared to 2012 (5,387).   
   
 Of the 1,935 cases identified nationally in 2014, 1,149 (59%) were classified as neuroinvasive 
disease (such as meningitis or encephalitis) and 786 (41%) were classified as non-neuroinvasive 
disease.  The majority of the cases were reported from nine states (California, Colorado, Illinois, 
Louisiana, Nebraska, and Texas). 43% of all cases were reported from California. 
                                                                                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Massachusetts, the vectors 
for WNV are primarily Culex 
species. Culex species are 
closely associated with 
human activity. The map to 
the right demonstrates 
transmission to humans is 
highest in counties with high 
population density. 
  
WNV Mosquito & Human Disease Correlation 
 
Of 5,039 mosquito samples collected in Massachusetts in 2014, 56 (1.1%) were positive for 
WNV. Positive mosquito samples included 52 (95 %) Culex species.  Positive samples were 
identified in 29 towns. 
 
In 2014, MDPH identified 52WNV positive Culex species mosquito samples as compared to 240 
WNV positive Culex species mosquito samples in 2013. Considering the decrease in human 
cases of WNV infection that occurred from 2012 to 2013/2014, a decline in WNV positive 
mosquito samples might have also been anticipated. As the graph below demonstrates, the 
percentage of WNV positive Culex mosquito samples declined slightly from 2012 to 2013, with 
a sharper decline in 2014. 
 
 
 
What are the expectations for WNV in 2015? 
 
The primary determinants of human WNV disease risk during any particular season are 
populations of Culex mosquito species and the presence of infected birds. The two most 
important variables for mosquito development are precipitation and temperature. Warmer 
temperatures shorten both the time it takes for mosquitoes to develop from egg to adult and the 
time it takes for a mosquito to be able to transmit a pathogen after ingesting an infected blood 
meal. Culex mosquito populations tend to be greatest during seasons with periodic precipitation 
events separated by hot, dry days (giving rise to stagnant puddles that favor Culex breeding). 
 
Mosquito populations alone are not sufficient to produce significant WNV risk; infected bird 
populations are also necessary.  Unfortunately, less is known about the factors that lead to large 
numbers of infected birds making this component of risk impossible to predict and there is no 
efficient way to conduct surveillance for infection levels in wild birds.  
 
The lack of useful pre-season predictive factors limits the ability of MDPH to make any accurate 
assessments regarding future WNV activity. Both the variability of New England weather, and 
the inability to detect WNV infection levels in wild bird populations, requires that Massachusetts 
maintain a robust surveillance system to detect WNV in mosquitoes as a primary tool to assess 
risk of human disease. MDPH continues to strive to identify reliable measures to aid in risk 
assessments.   
 
  
